Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
18 p, 3.4 MB Single-cell multi-omics analysis of COVID-19 patients with pre-existing autoimmune diseases shows aberrant immune responses to infection / Barmada, Anis (Department of Medical Genetics. University of Cambridge) ; Handfield, Louis-François (Wellcome Sanger Institute (Regne Unit)) ; Godoy-Tena, Gerard (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; de la Calle-Fabregat, Carlos (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Ciudad, Laura (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Arutyunyan, Anna (Wellcome Sanger Institute (Regne Unit)) ; Andrés-León, Eduardo (Instituto de Parasitología y Biomedicina "López-Neyra") ; Hoo, Regina (Wellcome Sanger Institute (Regne Unit)) ; Porter, Tarryn (Wellcome Sanger Institute (Regne Unit)) ; Oszlanczi, Agnes (Wellcome Sanger Institute (Regne Unit)) ; Richardson, Laura (Wellcome Sanger Institute (Regne Unit)) ; Calero-Nieto, Fernando (Department of Haematology and Wellcome & MRC Cambridge Stem Cell Institute. University of Cambridge) ; Wilson, Nicola K. (Department of Haematology and Wellcome & MRC Cambridge Stem Cell Institute. University of Cambridge) ; Marchese, Domenica (Centre de Regulació Genòmica) ; Sancho-Serra, Carmen (Wellcome Sanger Institute. Wellcome Genome Campus) ; Carrillo, Jorge (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Presas-Rodríguez, Silvia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ramo-Tello, Cristina (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Ruiz-Sanmartin, Adolfo (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ferrer, Ricard (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Ruiz-Rodriguez, Juan Carlos (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Martínez Gallo, Mónica (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Munera-Campos, Mónica (Institut Germans Trias i Pujol) ; Carrascosa, José Manuel (Institut Germans Trias i Pujol) ; Göttgens, Berthold (Department of Haematology and Wellcome & MRC Cambridge Stem Cell Institute. University of Cambridge) ; Heyn, Holger (Universitat Pompeu Fabra) ; Prigmore, Elena (Wellcome Sanger Institute (Regne Unit)) ; Casafont-Solé, Ivette (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Solanich, Xavier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sánchez-Cerrillo, Idelfonso (Department of Immunology. Hospital Universitario La Princesa) ; González-Álvaro, Isidoro (Rheumatology Service. Hospital Universitario La Princesa) ; Raimondo, Maria Gabriella (Deutsches Zentrum Immuntherapie. Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen) ; Ramming, Andreas (Deutsches Zentrum Immuntherapie. Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen) ; Martin, Javier (Instituto de Parasitología y Biomedicina "López-Neyra") ; Martínez Cáceres, Eva María (Universitat Autònoma de Barcelona. Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia) ; Ballestar, Esteban (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Vento-Tormo1, Roser (Wellcome Sanger Institute. Wellcome Genome Campus) ; Rodríguez-Ubreva, Javier (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras)
In COVID-19, hyperinflammatory and dysregulated immune responses contribute to severity. Patients with pre-existing autoimmune conditions can therefore be at increased risk of severe COVID-19 and/or associated sequelae, yet SARS-CoV-2 infection in this group has been little studied. [...]
2024 - 10.1002/eji.202350633
European Journal of Immunology, Vol. 54 Núm. 1 (january 2024) , p. 2350633  
2.
9 p, 872.2 KB The EHA research roadmap : normal hematopoiesis / Jaffredo, Thierry (Sorbonne Université. Institut de Biologie Paris Seine. Laboratoire de Biologie du Développement/UMR7622) ; Balduini, Alessandra (Department of Molecular Medicine. University of Pavia) ; Bigas Salvans, Anna (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bernardi, Rosa (IRCCS San Raffaele Scientific Institute (Milà, Itàlia)) ; Bonnet, Dominique (The Francis Crick Institute) ; Canque, Bruno (INSERM U976. Universite de Paris. Ecole Pratique des Hautes Etudes/PSL Research University. Institut de Recherche Saint Louis) ; Charbord, Pierre (Sorbonne Université. Institut de Biologie Paris Seine. Laboratoire de Biologie du Développement/UMR7622) ; Cumano, Anna (Unité Lymphopoïèse. Département d'Immunologie. INSERM U1223. Institut Pasteur. Cellule Pasteur. Université de Paris) ; Delwel, Ruud (Department of Hematology. Erasmus University Medical Center) ; Durand, Charles (Sorbonne Université. Institut de Biologie Paris Seine. Laboratoire de Biologie du Développement/UMR7622) ; Fibbe, Willem (Leiden University Medical Center) ; Forrester, Lesley (Centre for Regenerative Medicine. Institute for Regeneration and Repair. University of Edinburgh) ; De Franceschi, Lucia (Università degli Studi di Verona) ; Ghevaert, Cedric (University of Cambridge) ; Gjertsen, Bjørn. (Department of Clinical Science. Centre for Cancer Biomarkers CCBIO. University of Bergen) ; Gottgens, Berthold (Wellcome - MRC Cambridge Stem Cell Institute and Department of Haematology. University of Cambridge) ; Graf, Thomas (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Heidenreich, Olaf (Prinses Máxima Centrum voor kinderoncologie) ; Hermine, Olivier (Department of Hematology and Laboratory of Physiopathology and Treatment of Blood Disorders. Hôpital Necker. Imagine institute. University of Paris) ; Higgs, Douglas (MRC Weatherall Institute of Molecular Medicine. John Radcliffe Hospital) ; Kleanthous, Marina (The Cyprus Institute of Neurology and Genetics) ; Klump, Hannes (Institute for Transfusion Medicine. University Hospital Essen) ; Kouskoff, Valerie (University of Manchester) ; Krause, Daniela (Goethe University Frankfurt and Georg-Speyer-Haus) ; Lacaud, George (Cancer Research UK Manchester Institute. The University of Manchester) ; Lo Celso, Cristina (Imperial College London) ; Martens, Joost H.A. (Department of Molecular Biology. RIMLS. Radboud University) ; Méndez-Ferrer, Simón (University of Cambridge and NHSBT) ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Oostendorp, Robert (Department of Internal Medicine III. Technical University of Munich. School of Medicine) ; Philipsen, Sjaak (Department of Cell Biology. Erasmus University Medical Center Rotterdam) ; Porse, Bo (Novo Nordisk Foundation Center for Stem Cell Biology. DanStem. Faculty of Health Sciences. University of Copenhagen) ; Raaijmakers, Marc (Department of Hematology. Erasmus University Medical Center) ; Robin, Catherine (Regenerative medicine center. University Medical Center Utrecht) ; Stunnenberg, Henk (Prinses Máxima Centrum voor kinderoncologie) ; Theilgaard-Mönch, Kim (Department of Hematology. Rigshospitalet/National University Hospital. University of Copenhagen) ; Touw, Ivo (Department of Hematology. Erasmus University Medical Center) ; Vainchenker, William (Gustave Roussy) ; Corrons, Joan-Lluis V. (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Yvernogeau, Laurent (Sorbonne Université. Institut de Biologie Paris Seine. Laboratoire de Biologie du Développement/UMR7622) ; Schuringa, Jan Jacob (Department of Experimental Hematology. University Medical Center Groningen)
2021 - 10.1097/HS9.0000000000000669
HemaSphere, Vol. 5 Núm. 12 (30 2021) , p. e669  
3.
15 p, 4.2 MB GATA2 Promotes Hematopoietic Development and Represses Cardiac Differentiation of Human Mesoderm / Castaño Cardoso, Julio (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Aranda, Sergi (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Bueno, Clara (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Calero-Nieto, Fernando (Department of Hematology. Wellcome and MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research. University of Cambridge) ; Mejia-Ramirez, Eva (Centro de Medicina Regenerativa de Barcelona) ; Mosquera, José Luis (Institut d'Investigació Biomèdica de Bellvitge) ; Blanco, Enrique (Universitat Pompeu Fabra. Centre de Regulació Genòmica (CRG-UPF)) ; Wang, Xiaonan (Wellcome and MRC Cambridge Stem Cell Institute and Cambridge Institute for Medical Research. University of Cambridge) ; Prieto, Cristina (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Zabaleta, Lorea (Laboratory of Hematological Diseases. Fundación Inbiomed) ; Mereu, Elisabetta (Centre de Regulació Genòmica) ; Rovira, Meritxell (Centro de Medicina Regenerativa de Barcelona) ; Jiménez-Delgado, Senda (Centro de Medicina Regenerativa de Barcelona) ; Matson, Daniel Rusch (Department of Cell and Regenerative Biology. UW-Madison Blood Research Program. Carbone Cancer Center. University of Wisconsin School of Medicine and Public Health) ; Heyn, Holger (Universitat Pompeu Fabra) ; Bresnick, Emery H. (Department of Cell and Regenerative Biology. UW-Madison Blood Research Program. Carbone Cancer Center. University of Wisconsin School of Medicine and Public Health) ; Göttgens, Berthold (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Di Croce, Luciano (Institució Catalana de Recerca i Estudis Avançats) ; Menéndez Bujan, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Raya, Ángel (Institució Catalana de Recerca i Estudis Avançats) ; Giorgetti, Alessandra (Centro de Medicina Regenerativa de Barcelona) ; Universitat Autònoma de Barcelona
In vertebrates, GATA2 is a master regulator of hematopoiesis and is expressed throughout embryo development and in adult life. Although the essential role of GATA2 in mouse hematopoiesis is well established, its involvement during early human hematopoietic development is not clear. [...]
2019 - 10.1016/j.stemcr.2019.07.009
Stem cell reports, Vol. 13 Núm. 3 (october 2019) , p. 515-529  

Vea también: autores con nombres similares
2 Gottgens, B.
3 Gottgens, Berthold
2 Göttgens, B.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.